CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment Platform that will be customizable as an injection, to treat many types of cancer.
Powered by artificial intelligence, our revolutionary approach DETECTS, MARKS, and KILLS only cancer cells using the body’s own immune system. Other immunotherapies have had very limited success trying to teach the immune system how to recognize cancer cells. Instead, we intend to make cancer cells look like a common disease that it already recognizes, such as measles, and “trick” the body into killing these “disguised” cancer cells with strength.
We look forward to the day when treating cancer will be as simple as getting a shot.
Company Details
- Founded
- 2021
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cancervax.com
- Keywords
- IT Consulting.
Cancervax Biotech Questions
Cancervax Biotech's website is http://www.cancervax.com
Cancervax Biotech's LinkedIn profile is https://www.linkedin.com/company/cancervax-biotech
Cancervax Biotech's industry is
Biotechnology Research
Cancervax Biotech's top competitors are
Citizen Portal,
Blueflute,
Numurus, Inc,
Lumeova,
Kara Water,
Timeplast Inc.,
Vvolt,
Dice Cream Robotics,
Wigl,
Triagenics.com.
Cancervax Biotech's categories are Biotechnology Research
Cancervax Biotech's founding year is 2021
